PUBLIC HEALTH ASSESSMENT
PETER COOPER
GOWANDA, CATTARAUGUS COUNTY, NEW YORK
Figure 1. Gowanda Location Plan
Compound | Range of Detection mg/kg |
Number of Detects |
Total Samples |
Volatile & Semi-volatile Organics | |||
benzo(a)anthracene | 1.7-13 | 3 | 6 |
benzo(b)flouranthene | 2.7-13 | 2 | 5 |
benzo(k)flouranthene | 1.8-11 | 3 | 6 |
benzo(ghi)perylene | 6.6 | 1 | 6 |
* benzo(a)pyrene | 1.6-12 | 3 | 6 |
2-butanone | 0.14 | 1 | 1 |
chlorobenzene | 0.06 | 1 | 1 |
chrysene | 2.2-13 | 3 | 6 |
flouranthene | 2.6-4.2 | 5 | 6 |
indeno(123cd)pyrene | 6.6 | 1 | 6 |
4-methylphenol | 6.4 | 1 | 6 |
napthalene | 8.6 | 1 | 6 |
phenanthrene | 3.5-12 | 5 | 6 |
phenol | 0.79 | 1 | 6 |
pyrene | 2.7-18 | 4 | 6 |
Inorganics | |||
* arsenic | 6.2-33 | 11 | 11 |
* chromium (total) | 23-44000 | 11 | 11 |
hexavalent chromium | ND | 0 | 7 |
zinc | 62-921 | 4 | 4 |
mg/kg = milligrams per kilogram
ND = not detected
* indicates that contaminant selected for further evaluation -
See Table 7 for Public
Health Assessment Comparison Values
Table 2. Summary of Subsurface Soil Sample Results
mg/kg = milligrams per kilogram
ND = not detected
* indicates that contaminant selected for further evaluation -
See Table 7 for Public Health Assessment Comparison
Values
Table 3. Summary of Surface Soil Sample Results
Compound
|
Range of Detection mg/kg |
Number of Detects | Total Samples |
Range of Detection mg/kg |
Number of Detects | Total Samples |
|||||
Volatile & Semi-volatile Organics | On-site Samples | Background | |||||||||
acetone
|
0.022-0.5
|
3 | 3 | NA | |||||||
anthracene
|
0.1-0.92
|
3 | 13 | ND | 0 | 1 | |||||
benzo(a)anthracene
|
0.043-10
|
7 | 13 | 0.16 | 1 | 1 | |||||
benzo(b)flouranthene
|
0.088-8.8
|
7 | 13 | 0.31 | 1 | 1 | |||||
benzo(k)flouranthene
|
0.12-3.8
|
3 | 13 | ND | 0 | 1 | |||||
benzo(ghi)perylene
|
0.073-2.8
|
5 | 13 | 0.13 | 1 | 1 | |||||
* benzo(a)pyrene
|
0.043-7.8
|
7 | 13 | 0.17 | 1 | 1 | |||||
2-butanone
|
0.11-0.12
|
2 | 3 | NA | |||||||
carbon disulfide
|
0.004-0.004
|
1 | 5 | ND | 0 | 1 | |||||
carbazole
|
0.052
|
1 | 13 | ND | 0 | 1 | |||||
chrysene
|
0.074-9.1
|
7 | 13 | 0.19 | 1 | 1 | |||||
* dibenzo(ah)anthacene
|
0.056-1.6
|
3 | 13 | ND | 0 | 1 | |||||
1,2-dichlorobenzene
|
0.62-9.8
|
2 | 3 | NA | |||||||
1,1-dichloroethane
|
0.18
|
1 | 3 | NA | |||||||
flouranthene
|
0.037-14
|
9 | 13 | 0.37 | 1 | 1 | |||||
indeno(123cd)pyrene
|
0.065-4.2
|
5 | 13 | 0.13 | 1 | 1 | |||||
methylene chloride
|
0.18
|
1 | 3 | NA | |||||||
2-methylnapthalene
|
0.13-0.13
|
1 | 13 | ND | 0 | 1 | |||||
2-methylphenol
|
4.3
|
1 | 3 | NA | |||||||
4-methylphenol
|
0.47
|
1 | 3 | NA | |||||||
napthalene
|
0.078-5.4
|
3 | 13 | ND | 0 | 1 | |||||
2-nitrophenol
|
0.58-0.58
|
1 | 13 | ND | 0 | 1 | |||||
phenanthrene
|
0.056-2.9
|
7 | 13 | 0.16 | 1 | 1 | |||||
phenol
|
97-97
|
1 | 13 | ND | 0 | 1 | |||||
pyrene
|
0.047-12
|
8 | 13 | 0.28 | 1 | 1 | |||||
toluene
|
0.019
|
1 | 3 | NA | |||||||
Inorganics | |||||||||||
antimony
|
98.6
|
1 | 8 |
ND
|
0 | 1 | |||||
* arsenic
|
0.98-417
|
61 | 62 |
11-18
|
4 | 4 | |||||
chromium (total)
|
0.99-6220
|
63 | 63 |
17-34
|
4 | 4 | |||||
hexavalent chromium
|
0.014-24
|
35 | 55 |
ND
|
0 | 3 | |||||
zinc
|
8-1100
|
16 | 16 |
72-85.5
|
4 | 4 | |||||
NOTE: Surface soil samples were collected from either 0 to 3 inches in depth or 0 to 6 inches in depth |
mg/kg = milligrams per kilogram
ND = not detected
NA = not analyzed
* indicates that contaminant selected for further evaluation -
See Table 7 for Public Health Assessment Comparison
Values
Table 4. Summary of
Groundwater Sample Results
Compound | Range of Detection mcg/L |
Number of Detects | Total Samples |
|||
Unfiltered Groundwater | ||||||
Inorganics
|
||||||
arsenic
|
2-180
|
17 | 19 | |||
chromium (total)
|
4-1100
|
18 | 19 | |||
hexavalent chromium
|
5-420
|
18 | 19 | |||
zinc
|
20-11000
|
4 | 4 | |||
Filtered Groundwater | ||||||
Volatile & Semi-volatile Organics
|
||||||
chlorobenzene
|
26-130
|
2 | 4 | |||
2-chlorophenol
|
2.9
|
1 | 7 | |||
chrysene
|
9
|
1 | 7 | |||
dichlorobenzenes (total)
|
11
|
1 | 4 | |||
2-methylphenol
|
69
|
1 | 7 | |||
4-methylphenol
|
1200-42000
|
2 | 7 | |||
napthalene
|
1-16
|
2 | 7 | |||
phenol
|
99-8000
|
2 | 7 | |||
Inorganics | ||||||
arsenic
|
13-100
|
10 | 17 | |||
chromium (total)
|
4-890
|
16 | 19 | |||
hexavalent chromium
|
6-18
|
2 | 8 | |||
zinc
|
10-220
|
8 | 9 |
mcg/L = micrograms per liter
ND = not detected
* indicates that contaminant selected for further evaluation
-
See Table 7 for Public Health Assessment Comparison Values
Table 5. Summary of
Creek Water and Creek Sediment Sample Results
mcg/L = micrograms per liter
mg/kg = milligrams per kilogram
ND = not detected
* indicates that contaminant selected for further evaluation
-
See Table 7 for Public Health Assessment Comparison Values
Table 6. Summary of
Leachate Sample Results
Compound | Range of Detection mcg/L |
Number of Detects | Total Samples |
|||
Volatile & Semi-volatile Organics | ||||||
acetone
|
20-29
|
4 | 4 | |||
chlorobenzene
|
1-14
|
2 | 4 | |||
2,4-dimethylphenol
|
2
|
1 | 3 | |||
2-methylphenol
|
26
|
1 | 3 | |||
napthalene
|
2
|
1 | 4 | |||
phenol
|
1
|
1 | 3 | |||
toluene
|
10
|
1 | 4 | |||
zinc
|
2.9-52
|
8 | 8 | |||
Inorganics | ||||||
arsenic
|
10.2-98.8
|
8 | 10 | |||
chromium (total)
|
22.1-607
|
10 | 11 | |||
hexavalent chromium
|
0.65-116
|
10 | 11 | |||
magnesium
|
86500-160000
|
4 | 4 |
mcg/L = micrograms per liter
ND = not detected
* indicates that contaminant selected for further evaluation
-
See Table 7 for Public Health Assessment Comparison Values
Table 7. Public Health Assessment
Site-Specific Comparison Values (#) that are Exceeded
by Contaminants Found in Leachate, Subsurface Waste, Soil,
and/or Surface Water at or near the Peter Cooper Corporation Site
Contaminant | Soil Typical Background Range (mg/kg) |
Soil Comparison Values* (in mg/kg) | Water Comparison Values** (in mcg/L) |
|||||||
Cancer | Basis*** | Noncancer | Basis*** | Cancer | Basis*** | Noncancer | Basis*** | |||
Volatile and Semi-Volatile Organics | ||||||||||
benzo(a)pyrene
|
+ | 6.2 | EPA CPF | 60,000 | b | NA | -- | NA | -- | |
Inorganics | ||||||||||
arsenic
|
2-20C | 31 | EPA CPF | 600 | EPA RfD | 31 | EPA CPF | 1,800 | EPA RfD | |
chromium
|
10-60C | -- | -- | 16,000 | d | NA | -- | NA | -- |
mg/kg = milligrams per kilogram
mcg/L - micrograms per liter
* Comparison values for cancer risk are determined for a 70 kg adult who ingests 50 mg soil per day, 2 days per week for 3 months per year for 30 yrs out of a 70 yr lifetime. Comparison values for noncancer risk are determined for a 21 kg child who ingests 100 mg soil per day, 5 days per week for 6 months per year.
** Comparison values for cancer risk for are determined for a 70 kg adult who swallows 0.05 L of leachate or surface water per day, 2 days per week for 3 months per year for 30 yrs out of a 70 year lifetime. Comparison values for noncancer risk are determined for a 21 kg child and a 70 kg adult who swallow 0.05 L of leachate or surface water per day, 2 days per week for 3 months per year.
*** EPA CPF=EPA Cancer Potency
Factor
EPA RfD=EPA Reference Dose
NA=not applicable
+ Based on reported background
levels for total polycyclic aromatic hydrocarbons of 1 to 13 mg in soil (Edwards,
1983).
a- Comparison value based on
EPA CPF for benzo(a)pyrene and the US EPA (1993) interim relative potency factors
for polycyclic aromatic hydrocarbons.
b- Based on US EPA oral reference
dose for pyrene.
c- References: Clarke et al.
(1985), Connor et al. (1957), McGovern (1988), Shacklette and Boerngen (1984).
d- Based on dermal irritation
# These are site-specific comparison
values for the pathway(s) identified for this public health assessment.
These comparison values should not be used for other site
evaluations.
ATSDR Public Health Hazard Categories
CATEGORY / DEFINITION | DATA SUFFICIENCY | CRITERIA |
A. Urgent Public Health Hazard
This category is used for sites where short-term exposures (< 1 yr) to hazardous substances or conditions could result in adverse health effects that require rapid intervention. |
This determination represents a professional judgement based on critical data which ATSDR has judged sufficient to support a decision. This does not necessarily imply that the available data are complete; in some cases additional data may be required to confirm or further support the decision made. | Evaluation of available relevant information* indicates that site-specific conditions or likely exposures have had, are having, or are
likely to have in the future, an adverse impact on human health that
requires immediate action or intervention. Such site-specific
conditions or exposures may include the presence of serious
physical or safety hazards. |
B. Public Health Hazard
This category is used for sites that pose a public health hazard due to the existence of long-term exposures (> 1 yr) to hazardous substance or conditions that could result in adverse health effects. |
This determination represents a professional judgement based on critical data which ATSDR has judged sufficient to support a decision. This does not necessarily imply that the available data are complete; in some cases additional data may be required to confirm or further support the decision made. | Evaluation of available relevant information* suggests that, under site-specific conditions of exposure, long-term exposures to site-specific contaminants (including radionuclides) have had, are having, or are likely to have in the future, an adverse impact on human health that requires one or more public health interventions. Such site-specific exposures may include the presence of serious physical or safety hazards. |
C. Indeterminate Public Health Hazard
This category is used for sites in which "critical" data are insufficient with regard to extent of exposure and/or toxicologic properties at estimated exposure levels. |
This determination represents a professional judgement that critical data are missing and ATSDR has judged the data are insufficient to support a decision. This does not necessarily imply all data are incomplete; but that some additional data are required to support a decision. | The health assessor must determine, using professional judgement, the "criticality" of such data and the likelihood that the data can be obtained and will be obtained in a timely manner. Where some data are available, even limited data, the health assessor is encouraged to the extent possible to select other hazard categories and to support their decision with clear narrative that explains the limits of the data and the rationale for the decision. |
D. No Apparent Public Health Hazard
This category is used for sites where human exposure to contaminated media may be occurring, may have occurred in the past, and/or may occur in the future, but the exposure is not expected to cause any adverse health effects. |
This determination represents a professional judgement based on critical data which ATSDR considers sufficient to support a decision. This does not necessarily imply that the available data are complete; in some cases additional data may be required to confirm or further support the decision made. | Evaluation of available relevant information* indicates that, under site-specific conditions of exposure, exposures to site-specific contaminants in the past, present, or future are not likely to result in any adverse impact on human health. |
E: No Public Health Hazard
This category is used for sites that, because of the absence of exposure, do NOT pose a public health hazard. |
Sufficient evidence indicates that no human exposures to contaminated media have occurred, none are now occurring, and none are likely to occur in the future |
NEW YORK STATE DEPARTMENT OF HEALTH
PROCEDURE FOR EVALUATING POTENTIAL HEALTH RISKS
FOR CONTAMINANTS OF CONCERN
To evaluate the potential health risks from contaminants of concern associated with the Peter Cooper Corporation site, the New York State Department of Health assessed the risks for cancer and noncancer health effects.
Increased cancer risks were estimated by using site-specific information on exposure levels for the contaminant of concern and interpreting them using cancer potency estimates derived for that contaminant by the US EPA or, in some cases, by the NYS DOH. The following qualitative ranking of cancer risk estimates, developed by the NYS DOH, was then used to rank the risk from very low to very high. For example, if the qualitative descriptor was "low", then the excess lifetime cancer risk from that exposure is in the range of greater than one per million to less than one per ten thousand. Other qualitative descriptors are listed below:
Excess Lifetime Cancer Risk
|
|
Risk Ratio
|
Qualitative Descriptor
|
equal to or less than one in a million
|
very low
|
greater than one in a million to less than one in ten
thousand
|
low |
one in ten thousand to less than one in a thousand |
moderate
|
one in a thousand to less than one in ten |
high
|
equal to or greater than one in ten
|
very high
|
An estimated increased excess lifetime cancer risk is not a specific estimate of expected cancers. Rather, it is a plausible upper bound estimate of the probability that a person may develop cancer sometime in his or her lifetime following exposure to that contaminant.
There is insufficient knowledge of cancer mechanisms to decide if there exists a level of exposure to a cancer-causing agent below which there is no risk of getting cancer, namely, a threshold level. Therefore, every exposure, no matter how low, to a cancer-causing compound is assumed to be associated with some increased risk. As the dose of a carcinogen decreases, the chance of developing cancer decreases, but each exposure is accompanied by some increased risk.
There is general consensus among the scientific and regulatory communities on what level of estimated excess cancer risk is acceptable. An increased lifetime cancer risk of one in one million or less is generally considered an insignificant increase in cancer risk.
For noncarcinogenic health risks, the contaminant intake was estimated using
exposure assumptions for the site conditions. This dose was then compared to
a risk reference dose (estimated daily intake of a chemical that is likely to
be without an appreciable risk of health effects) developed by the US EPA, ATSDR
and/or NYS DOH. The resulting ratio was then compared to the following qualitative
scale of health risk:
Noncarcinogenic Health Risks |
|
Ratio of Estimated Contaminant |
Qualitative
Descriptor |
equal to or less than the reference dose or minimal risk level |
minimal
|
greater than one to five times the reference dose or minimal risk level |
low
|
greater than five to ten times |
moderate
|
greater than ten times the reference dose or minimal risk level |
high
|
Noncarcinogenic effects unlike carcinogenic effects are believed to have a threshold, that is, a dose below which adverse effects will not occur. As a result, the current practice is to identify, usually from animal toxicology experiments, a no-observed-effect-level (NOEL). This is the experimental exposure level in animals at which no adverse toxic effect is observed. The NOEL is then divided by an uncertainty factor to yield the risk reference dose. The uncertainty factor is a number which reflects the degree of uncertainty that exists when experimental animal data are extrapolated to the general human population. The magnitude of the uncertainty factor takes into consideration various factors such as sensitive subpopulations (for example, children or the elderly), extrapolation from animals to humans, and the incompleteness of available data. Thus, the risk reference dose is not expected to cause health effects because it is selected to be much lower than dosages that do not cause adverse health effects in laboratory animals.
The measure used to describe the potential for noncancer health effects to occur in an individual is expressed as a ratio of estimated contaminant intake to the risk reference dose. If exposure to the contaminant exceeds the risk reference dose, there may be concern for potential noncancer health effects because the margin of protection is less than that afforded by the reference dose. As a rule, the greater the ratio of the estimated contaminant intake to the risk reference dose, the greater the level of concern. A ratio equal to or less than one is generally considered an insignificant (minimal) increase in risk.
This summary was prepared to address comments and questions on the public comment draft of the Peter Cooper - Gowanda Public Health Assessment. The public was invited to review the draft during the public comment period, which ran from February 29, 2000 -- April 14, 2000. We received one response, which was from a public agency. Some statements were reworded for clarity and brevity. If you have any questions about this summary, you can contact the New York State Department of Health's (NYS DOH) Outreach Unit at the toll free number: 1-800-458-1158, extension 27530.
Comment #1 - In Section D, Health Outcome Data, health outcome data bases are described. Are they available to the public, and where can the public obtain information in these databases?
Response #1 - These databases contain confidential medical information that is protected from public disclosure by law. The databases are used by health agencies and researchers. To provide information to the public, while at the same time protecting confidentiality, the data are often aggregated and provided to the public at the county level. As part of the NYS DOH Cancer Surveillance Initiative, the number of observed and expected cases of cancer are being provided at the ZIP code level for some of the common types cancers. For more information on the availability of summary level health outcome data the public can either check the NYS Department of Health's Web site at www.health.state.ny.us or call 1-800-458-1158.
For the ATSDR public health assessment program, we use the databases to evaluate possible adverse health outcomes when there is documentation of significant exposures to chemicals at waste sites.
Comment #2 - In the Recommendations Section, are there other remedies, such as removal, that would also be protective of public health?
Response #2 - The Recommendations Section indicates that any remedy that prevents public exposures will be considered. Removal of the wastes from the site could be an alternative to encapsulating the wastes on-site. However, the final remedy will be selected after the environmental investigations are complete.